DLVR Therapeutics is developing an innovative, HDL-like Peptide-Phospholipid Scaffold (HPPS) nanoparticle delivery system, initially for RNAi therapeutics.

DLVR Therapeutics – nanoparticle drug delivery system

Continue reading →